Sundance Resources (SDL) Takeover News|ASX SDL|SDL SharesSundance Resources (ASX:SDL) is an Australian-based international iron ore company developing the Mbalam Project in the Republic of Cameroon in the central west coast of Africa.

The group entered into a trading halt yesterday ahead of a planned announcement on the takeover offer from Hanlong.

The announcement, which was made today, said that SDL has backed a revised $1.65 billion bid from Hanlong.  The bid was sweetened from the previous $1.44 billion.

At 57 cents per share, the offer represents a 33% premium to SDL’s last closing price on 30 September.

SDL was one of the hot stocks in the weeks surrounding the original offer that was made in July.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!


   Written by: admin   Other posts from: admin

ASX Stocks to Watch: AWE Limited (AWE)|ASX AWE|AWE SharesAWE Limited (ASX:AWE) is a small oil and gas explorer and producer. The majority of its operations are located in Australia and New Zealand, though the company is becoming increasingly interested in international operations.

The company’s major projects are the onshore Casino gas field (Otway Basin, SA), Cliff Head project (Perth Basin, WA) and the BassGas project (VIC & TAS) and now, the Perth Basin.

Over the last year, AWE has underperformed its peers hurt by a shift in its growth focus from conventional exploration plays to unconventional Australian/US plays. It has also suffered from some reserves downgrades over the past 12 months and it has generally been one of the shares to sell over the period.

Macroeconomic factors have seen significant weakness in the commodities space which has resulted in a huge selloff in resource stocks.

Being an explorer, AWE’s share price is largely driven by sentiment and commodity prices. With both turning negative, we feel AWE has significant downside risk.

Earnings need oiling

Last month, AWE announced a FY11 net loss of $117.6 million, which compared to a $28.9 million loss a year earlier.

Excluding one-off items, the underlying loss was $16.1 million.

Revenue for the period fell 14% to $305 million, with oil production down sharply from the prior year.  However, this was partly offset by stronger oil prices and gas sales.

This revenue was achieved on production of around 6.1mmboe.

AWE forecast FY12 production of 5.0mmboe – 5.5mmboe, and revenue between $270 million and $300 million.

This production forecast is lower than FY11’s production due to a four to six month Bass Gas outage.

It has budgeted $50 million for exploration expenditure and $150 million for development expenditure.

Looking ahead

In its operating budget for FY12, AWE hopes to deliver this revenue at a US$100/bbl brent oil price.

We feel this price is highly optimistic considering the current global economic conditions.

Oil prices are already down to around US$81/bbl with forecasts pointing towards an even lower price.

Just over the past month, brokers have downgraded earnings forecasts for AWE by around 20% to 30%.

During market downturns, investors tend to use share price weakness as an opportunity to buy established producers at significant discounts which leaves the explorers like AWE out to dry.

With risk appetite swiftly disappearing in global markets, we are likely to see energy commodities and subsequently energy stocks like AWE continue to be sold off.  It will be one of the stocks to watch in coming months.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 14 2011


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 13 2011


   Written by: admin   Other posts from: admin

Health Care Stocks News: Cochlear (COH)|ASX COH|COH SharesCochlear (ASX:COH) is a world leader in restoring hearing to profoundly hearing-impaired patients.

The company currently occupies a 70% share of the world market for the profoundly hearing impaired (PHI), selling its products in over 100 countries.

COH shares have been smashed today after the group recalled its latest hearing implant range.

The voluntary recall of COH’s Nucleus CI500 range was in response to a recent increase in implant failures.

The group’s shares have been trading lower by more than 20% so far today, making COH the worst performer in the stock market.

Receive FREE Trading Recommendations for the next 7 Days, Click Here!


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 12 2011


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 7 2011


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 6 2011


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 5 2011


   Written by: admin   Other posts from: admin

Daily Global Financial Markets Video News September 2 2011


   Written by: admin   Other posts from: admin
7 day free trial
 



asx-share-price

To start your Free 7 day trial please complete your details below

* required fields

IMPORTANT: an activation code will be sent via SMS, please enter your preferred mobile number



Disclaimer: The content of this blog does not constitute a recommendation nor does it take into account your investment objectives, financial situation nor particular needs. Before acquiring or using any of Australian Stock Report's products, you should obtain and consider our Financial Services Guide. Australian Stock Report Ltd (ACN 106 863 978) is licensed as an Australian Financial Services Licensee pursuant to section 913B of the Corporations Act 2001. AFS Licence 301682. Any content within this email remains the property of Australian Stock Report and should not be reproduced without the consent of Australian Stock Report
RSS Feed